TNFSF9 Polyclonal Antibody, APC-Cy5.5 Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bs-3851R-APC-Cy5.5-100uL |
| Product Name | TNFSF9 Polyclonal Antibody, APC-Cy5.5 Conjugated |
| Applications |
WB
IF(IHC-P)
IF(IHC-F)
IF(ICC)
|
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | APC-Cy5.5 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human TNFSF9 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 8744 |
| Swiss Prot | P41273 |
| Subcellular location | Cell membrane |
| Synonyms | CD137L; 4-1BB-L; Tumor necrosis factor ligand superfamily member 9; 4-1BB ligand; 4-1BBL; TNFSF9 |
| Background | Cytokine that binds to TNFRSF9. Induces the proliferation of activated peripheral blood T-cells. May have a role in activation-induced cell death (AICD). May play a role in cognate interactions between T-cells and B-cells/macrophages. |
| Application Dilution | |
| WB | 1:300-5000 |
| IF(IHC-P) | 1:50-200 |
| IF(IHC-F) | 1:50-200 |
| IF(ICC) | 1:50-200 |
Frequently asked questions
Which applications is TNFSF9 Polyclonal Antibody, APC-Cy5.5 Conjugated (BS-3851R-APC-CY5-5) validated for, and at what dilution?
BS-3851R-APC-CY5-5 is validated for WB (1:300-5000); IF(IHC-P) (1:50-200); IF(IHC-F) (1:50-200); IF(ICC) (1:50-200). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does TNFSF9 Polyclonal Antibody, APC-Cy5.5 Conjugated (BS-3851R-APC-CY5-5) react with?
Tested reactivity: Human, Mouse, Rat.
How should BS-3851R-APC-CY5-5 be stored?
Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise TNFSF9 Polyclonal Antibody, APC-Cy5.5 Conjugated (BS-3851R-APC-CY5-5)?
KLH conjugated synthetic peptide derived from human TNFSF9
What are the excitation and emission wavelengths of the APC-Cy5.5 conjugate (BS-3851R-APC-CY5-5)?
APC-Cy5.5 on BS-3851R-APC-CY5-5: excitation / emission 650nm/694nm.